OKLAHOMA CITY–(BUSINESS WIRE)–Federman & Sherwood reminds investors of the approaching deadline of October 18, 2021, in the class action lawsuit against Sesen Bio (NASDAQ: SESN). The complaint alleges violations of federal securities laws, Sections 10(b)…
